Keyphrases
Adrenergic alpha-antagonists
100%
Benign Prostatic Hypertrophy
100%
Patients with Heart Failure
100%
Heart Failure
66%
Confidence Interval
44%
Hazard Ratio
44%
Heart Failure Hospitalization
33%
All-cause Mortality
22%
Beta-blockers
22%
Acute Decompensated Heart Failure
22%
Benign Prostatic Hyperplasia
22%
Hypertension
11%
Clinical Trials
11%
Rehospitalization
11%
Clinical Outcomes
11%
Harmful Effects
11%
Non-associated
11%
At Discharge
11%
Failure Rate
11%
Cox Proportional Hazards Model
11%
Mortality Hazard
11%
Failure Hazard
11%
Patients with Chronic Heart Failure
11%
Veterans Affairs Hospital
11%
Combined Risk
11%
Total Mortality
11%
Contemporary Therapy
11%
Heart Failure Admission
11%
Heart Failure Mortality
11%
Symptomatic Benign Prostatic Hyperplasia
11%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Prostate Hypertrophy
100%
Alpha 1 Adrenergic Receptor Blocking Agent
100%
Adrenergic Receptor Blocking Agent
50%
All Cause Mortality
14%
Clinical Trial
7%